There is little doubt that Dr. Williams’ expertise and sustained leadership have had an important positive impact on public health .
(PRWEB) July 16, 2015
Roger Williams, MD, a Premier Expert Consultant with NDA Partners LLC, former Chief Executive Officer of the US Pharmacopeial Convention (USP) and Chair of the USP Council of Experts, was recently recognized by the American Pharmacists Association (APhA) Board of Trustees for his contributions to ensuring the quality and safety of medications in the United States. The citation from APhA is conferred upon individuals, either within the profession of pharmacy or outside of it, whose activities and achievements have had a significant impact on public health, the profession, and its practitioners. While at USP, Dr. Williams championed the use of public testing standards to assure the quality, safety, and benefit of food and medications. During his tenure, USP experienced substantial growth in the number of volunteers and staff, global linkages, scientific focus, and financial stability.
“This is a significant and well earned recognition of Roger Williams’ contributions”, said Dr. Carl Peck, Chairman of NDA Partners. “There is little doubt that Dr. Williams’ expertise and sustained leadership have had an important positive impact on public health, and the citation recently conferred by APhA further affirms the significance of his contributions to the industry.”
The American Pharmacist Association, founded in 1852, is the largest association of pharmacists in the United States, with more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians as members. USP is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. These standards are enforceable in the United States by the Food and Drug Administration, and used in more than 140 countries. The Council of Experts is the body that oversees USP's scientific and standards-setting decisions.
About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 60 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.